Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-1.794; its P/E ratio is -3.15; Sutro Biopharma is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 113.72M	$ 16.92M	$ 10.41M	$ 12.67M	$ 8.63M
Gross Profit	$ 113.72M	$ 16.92M	$ 10.41M	$ 12.67M	$ 11.42M
EBIT	$ 46.97M	$ -47.15M	$ -37.97M	$ -50.16M	$ -35.75M
EBITDA	$ 45.63M	-	$ -38.08M	$ -50.33M	$ -35.39M
Net Income Common Stockholders	$ 16.06M	$ -40.57M	$ -38.52M	$ -50.05M	$ -34.59M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 375.62M	$ 355.15M	$ 391.64M	$ 276.49M	$ 334.36M
Total Assets	$ 470.74M	$ 431.73M	$ 464.90M	$ 358.02M	$ 406.94M
Total Debt	$ 33.63M	$ 38.17M	$ 42.66M	$ 46.56M	$ 50.43M
Net Debt	$ -341.98M	$ -316.98M	$ -348.99M	$ -229.93M	$ -283.93M
Total Liabilities	$ 321.09M	$ 319.39M	$ 310.18M	$ 172.60M	$ 189.90M
Stockholders Equity	$ 149.65M	$ 112.35M	$ 154.70M	$ 185.41M	$ 217.05M
Cash Flow	-
Free Cash Flow	$ 14.07M	-	$ -31.20M	$ -60.99M	$ -23.86M
Operating Cash Flow	$ 14.07M	$ -33.50M	$ -31.20M	$ -60.99M	$ -23.86M
Investing Cash Flow	$ -23.51M	$ -114.02M	$ 66.16M	$ 67.45M	$ -37.88M
Financing Cash Flow	$ -3.13M	$ -5.74M	$ 137.66M	$ 8.76M	$ 12.22M

Currency in USD

Sutro Biopharma Earnings and Revenue History

Income Statement >

Sutro Biopharma Debt to Assets

Balance Sheet >

Sutro Biopharma Cash Flow

Cash Flow >

Sutro Biopharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing